Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test.

Verster JC, Veldhuijzen DS, Patat A, Olivier B, Volkerts ER.

Curr Drug Saf. 2006 Jan;1(1):63-71.

PMID:
18690916
2.

Meta-analysis of on-the-road experimental studies of hypnotics: effects of time after intake, dose, and half-life.

Roth T, Eklov SD, Drake CL, Verster JC.

Traffic Inj Prev. 2014;15(5):439-45. doi: 10.1080/15389588.2013.830211. Review.

PMID:
24678565
3.

Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.

Verster JC, Volkerts ER, Schreuder AH, Eijken EJ, van Heuckelum JH, Veldhuijzen DS, Verbaten MN, Paty I, Darwish M, Danjou P, Patat A.

J Clin Psychopharmacol. 2002 Dec;22(6):576-83.

PMID:
12454557
4.

Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.

Vermeeren A, Vuurman EF, Leufkens TR, Van Leeuwen CJ, Van Oers AC, Laska E, Rico S, Steinberg F, Roth T.

Sleep. 2014 Mar 1;37(3):489-96. doi: 10.5665/sleep.3482.

5.

Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.

Mets MA, de Vries JM, de Senerpont Domis LM, Volkerts ER, Olivier B, Verster JC.

Sleep. 2011 Oct 1;34(10):1327-34. doi: 10.5665/SLEEP.1272.

6.

Middle-of-the-night administration of sleep medication: a critical review of the effects on next morning driving ability.

Verster JC, van de Loo AJ, Moline ML, Roth T.

Curr Drug Saf. 2014;9(3):205-11. Review.

PMID:
24909576
7.

Residual effects of sleep medication on driving ability.

Verster JC, Veldhuijzen DS, Volkerts ER.

Sleep Med Rev. 2004 Aug;8(4):309-25. Review.

PMID:
15233958
8.

Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving ability.

Verster JC, Spence DW, Shahid A, Pandi-Perumal SR, Roth T.

Curr Drug Saf. 2011 Sep 1;6(4):209-18. Review.

PMID:
22129315
9.

Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies.

Leufkens TR, Vermeeren A.

Clin Ther. 2014 Jan 1;36(1):141-50. doi: 10.1016/j.clinthera.2013.11.005. Epub 2013 Dec 17.

10.

Lapses of attention as outcome measure of the on-the-road driving test.

Verster JC, Bervoets AC, de Klerk S, Roth T.

Psychopharmacology (Berl). 2014 Jan;231(1):283-92. doi: 10.1007/s00213-013-3236-0. Epub 2013 Aug 24.

PMID:
23975036
11.

Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo.

Leufkens TR, Vermeeren A.

J Clin Psychopharmacol. 2009 Oct;29(5):432-8. doi: 10.1097/JCP.0b013e3181b57b43.

PMID:
19745642
12.

Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.

Ramaekers JG, Conen S, de Kam PJ, Braat S, Peeters P, Theunissen EL, Ivgy-May N.

Psychopharmacology (Berl). 2011 May;215(2):321-32. doi: 10.1007/s00213-010-2149-4. Epub 2011 Jan 19.

13.

Zolpidem and traffic safety - the importance of treatment compliance.

Verster JC, Volkerts ER, Olivier B, Johnson W, Liddicoat L.

Curr Drug Saf. 2007 Sep;2(3):220-6. Review.

PMID:
18690971
14.

Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol.

Vermeeren A, Riedel WJ, van Boxtel MP, Darwish M, Paty I, Patat A.

Sleep. 2002 Mar 15;25(2):224-31.

PMID:
11905433
15.

Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.

Leufkens TR, Lund JS, Vermeeren A.

J Sleep Res. 2009 Dec;18(4):387-96. doi: 10.1111/j.1365-2869.2009.00746.x. Epub 2009 Jun 22.

16.

Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.

Otmani S, Demazières A, Staner C, Jacob N, Nir T, Zisapel N, Staner L.

Hum Psychopharmacol. 2008 Dec;23(8):693-705. doi: 10.1002/hup.980.

PMID:
18763235
17.

Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia.

Partinen M, Hirvonen K, Hublin C, Halavaara M, Hiltunen H.

Sleep Med. 2003 Nov;4(6):553-61.

PMID:
14607350
18.

Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.

Ramaekers JG.

J Clin Psychiatry. 2003 Jan;64(1):20-9. Review.

PMID:
12590619
19.

Residual effects of hypnotic drugs in aging drivers submitted to simulated accident scenarios: an exploratory study.

Meskali M, Berthelon C, Marie S, Denise P, Bocca ML.

Psychopharmacology (Berl). 2009 Dec;207(3):461-7. doi: 10.1007/s00213-009-1677-2. Epub 2009 Oct 2.

PMID:
19798483
20.

Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent.

Patat A, Paty I, Hindmarch I.

Hum Psychopharmacol. 2001 Jul;16(5):369-392.

PMID:
12404558
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk